Showing 1 - 2 results of 2 for search 'Gail J. Roboz', query time: 0.01s Refine Results
  1. 1
    Deficit accumulation frailty index and treatment tolerability in AML: data from CALGB 11001 and 11002 (Alliance)

    Deficit accumulation frailty index and treatment tolerability in AML: data from CALGB 11001 and 11002 (Alliance) by Catherine Lai, Minji Lee, Olivia Bobek, Jennifer Le-Rademacher, Sumithra Mandrekar, Gail J. Roboz, Geoffrey L. Uy, Jeanne S. Mandelblatt, Heidi D. Klepin

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trial

    Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phas... by Jorge E. Cortes, Gail J. Roboz, Maria R. Baer, Brian A. Jonas, Gary J. Schiller, Karen Yee, P. Brent Ferrell, Jay Yang, Eunice S. Wang, William G. Blum, Alice Mims, Hua Tian, Aaron Sheppard, Stéphane de Botton, Pau Montesinos, Antonio Curti, Justin M. Watts, the Olutasidenib Combination Therapy Study Group

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: